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Endothelial Cells from Oxidative Stress through Interaction
with Histone Deacetylase 3*
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Background: The role of the unspliced XBP1 remains unclear.
Results:Disturbed flow concomitantly up-regulates XBP1u and HDAC3, which form a complex with Akt1 andmTOR, leading
to Nrf2-mediated HO-1 expression.
Conclusion: XBP1u and HDAC3 synergistically exert a protective effect on disturbed flow-induced oxidative stress via regula-
tion of HO-1 expression.
Significance: This study provides new insights into the physiological roles of XBP1u and HDAC3.
It is well known that atherosclerosis occurs geographically at
branch points where disturbed flow predisposes to the develop-
ment of plaque via triggering of oxidative stress and inflammatory
reactions. Inthis study,wefoundthatdisturbedflowactivatedanti-
oxidative reactions via up-regulating heme oxygenase 1 (HO-1) in
an X-box-binding protein 1 (XBP1) and histone deacetylase 3
(HDAC3)-dependent manner. Disturbed flow concomitantly
up-regulated the unspliced XBP1 (XBP1u) and HDAC3 in a
VEGF receptor andPI3K/Akt-dependentmanner. Thepresence
of XBP1 was essential for the up-regulation of HDAC3 protein.
Overexpression of XBP1u and/or HDAC3 activated Akt1 phos-
phorylation, Nrf2 protein stabilization and nuclear transloca-
tion, andHO-1 expression. KnockdownofXBP1udecreased the
basal level and disturbed flow-induced Akt1 phosphorylation,
Nrf2 stabilization, and HO-1 expression. Knockdown of
HDAC3 ablated XBP1u-mediated effects. The mammalian tar-
get of rapamycin complex 2 (mTORC2) inhibitor, AZD2014,
ablated XBP1u or HDAC3 or disturbed flow-mediated Akt1
phosphorylation, Nrf2 nuclear translocation, and HO-1 expres-
sion. Neither actinomycin D nor cycloheximide affected dis-
turbed flow-induced up-regulation ofNrf2 protein. Knockdown
of Nrf2 abolished XBP1u or HDAC3 or disturbed flow-induced
HO-1 up-regulation. Co-immunoprecipitation assays demon-
strated that XBP1u physically bound to HDAC3 and Akt1. The
region of amino acids 201 to 323 of the HDAC3 protein was
responsible for the binding to XBP1u. Double immunofluores-
cence staining revealed that the interactions between Akt1 and
mTORC2, Akt1 and HDAC3, Akt1 and XBP1u, HDAC3, and
XBP1u occurred in the cytosol. Thus, we demonstrate that
XBP1u and HDAC3 exert a protective effect on disturbed
flow-induced oxidative stress via up-regulation ofmTORC2-de-
pendent Akt1 phosphorylation and Nrf2-mediated HO-1
expression.
It is widely accepted that atherosclerosis occurs geographi-
cally at branch points where disturbed flow can trigger endo-
thelial cell (EC)4 dysfunction via oxidative stress and inflamma-
tion (1). Under physiological conditions, cells can naturally
establish homeostasis in response to different stimuli. Theoret-
ically, the activation of oxidative stress under disturbed flow
should be accompanied by the up-regulation of anti-oxidative
mechanisms to maintain homeostasis within ECs. This may be
a mechanism through which vascular integrity is maintained.
The development of atherosclerosis could be a consequence of
the disruption of the homeostasis by the intervention of other
risk factors such as hyperlipidemia, diabetes, hypertension,
smoking, and etc. (2, 3).
Heme oxygenase 1 (HO-1) is an inducible isoform of the
heme oxygenase family, which catalyzes the degradation of
heme, producing biliverdin, iron, and carbon monoxide (4).
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HO-1 was originally identified as a 32-kDa stress responsive
protein to UV-irradiation, hydrogen peroxide, and sodium
arsenite (5).HO-1 is inducedubiquitously in cells in response to
oxidative stress, hypoxia, heavy metal ions, cytokines, glutathi-
one depletion, and etc. (6). The induction of HO-1 and the
derived carbon monoxide plays a protective role against cell
apoptosis (7). Disruption of the HO-1gene (HMOX-1) does not
affect mouse survival but increases end-organ damage and
mortality during endotoxemia due to increased oxidative stress
(8). In EC, HO-1 can be induced by both laminar flow and dis-
turbed flow through oxidative stress and Nrf2 (NF-E2-related
factor 2) activation (9). However, the existence of a signaling
pathway between the mechanosensor and Nrf2-mediated
HO-1 expression remains unknown.
The X-box binding protein 1 (XBP1) is also a stress respon-
sive gene. In contrast to most stress responsive genes, XBP1
mRNA undergoes alternative splicing via inositol-requiring
enzyme 1  (IRE1). This occurs in response to endoplasmic
reticulum (ER) stress, resulting in an open reading frameshift
(10, 11). XBP1 protein exists as 29-kDa unspliced (XBP1u) and
56-kDa spliced (XBP1s) isoforms. Both isoforms have an iden-
tical N-terminal dimerization domain and internal DNA bind-
ing domain but differ in the C terminus. XBP1s contains a tran-
scriptional activation domain in the C terminus and functions
as an intact transcription factor (10). The majority of the previ-
ously described XBP1 functions are assigned to XBP1s. Our
previous studies have demonstrated that XBP1s plays multiple
roles in EC proliferation, autophagy response, and apoptosis
(12–14). The C terminus of XBP1u contains a signal for protea-
some-mediated degradation, negatively regulatingXBP1s func-
tion (15). There remains very little investigation into the role of
XBP1u compared with XBP1s.
Histone deacetylase 3 (HDAC3) is a class I HDAC (16). Dis-
ruption of theHDAC3 gene is lethal at an early embryonic stage
(17). It is reported that cigarette smoke reducesHDAC3activity
via posttranslational modification (18), which is the first indi-
rect evidence that HDAC3 is involved in response to oxidative
stress. Our previous study provides direct evidence that up-reg-
ulation of HDAC3 by disturbed flow is essential for EC survival
under oxidative stress via activation of Akt phosphorylation
(19). HDAC3 deficiency in ECs accelerates vessel injury-induced
neointima formation. Our studies have also demonstrated that
HDAC3homeostasis is essential for ECdifferentiation fromstem/
progenitor cells (20, 21), inflammatory reactions (22), and endo-
thelial-to-mesenchymal transition (23). In this study, we found
that HDAC3 cooperated with XBP1u to modulate HO-1 expres-
sion in response to disturbed flow. To scrutinize the molecular
mechanisms of this process, the present study aims to clarify the
role of XBP1 interaction with the partners in maintaining endo-
thelial functions. We demonstrated that an interaction between
XBP1 and HADC3 resulted in PI3K/Akt1 activation and HO-1
expression. This process is crucial for endothelial survival in
response to oxidative stress.
EXPERIMENTAL PROCEDURES
Materials—All cell culture medium and serum were pur-
chased from Invitrogen, whereas cell culture supplements were
purchased from Sigma. Antibodies against XBP1 (sc-7160),
HDAC3 (sc-136290) phospho-Akt (sc-7985R), Akt1 (sc-1619),
Nrf2 (sc-722), mTOR (sc-1549), histone H3 (sc-10809), IRE1
(sc-20790), andGAPDH (sc-25778)were purchased fromSanta
Cruz Biotechnology; antibodies against FLAG (F2426, F1804,
and F7425), HA (H6908) and tubulin (T8203) were fromSigma;
antibody against HO-1 (ab13248) was purchased from Abcam.
Antibodies against XBP1u and XBP1s were raised in rabbits
with peptides CRSSQRSTQKDPVPY and DSGGIDSSDSES-
DIC, respectively, by GenScript Corp. All secondary antibodies
were from DakoCytomation. Inhibitors LY294002, PD98059,
SU5416, actinomycin D, cycloheximide, and Tin protoporphy-
rin IX were purchased from Sigma. AZD2014 was purchased
from Selleckchem. All inhibitors were dissolved in DMSO. All
other chemicals were also from Sigma.
Cell Culture—Human umbilical vein ECs (HUVECs) were
cultured on 0.04% gelatin-coated flasks in M199 medium sup-
plemented with 1 ng/ml -EC growth factor, 3 g/ml EC
growth supplement from bovine neural tissue, 10/ml heparin,
1.25 g/ml thymidine, 10% fetal bovine serum (FBS), 100 /ml
penicillin, and streptomycin in a humidified incubator supple-
mented with 5%CO2. The cells were split every 3 days at a ratio
of 1:3. Cells up to passage 10 were used in this study. HEK293
cells were maintained in DMEM supplemented with 10% FBS
and penicillin/streptomycin and were split every 3 days at a
ratio of 1:4. Mouse embryonic fibroblasts were isolated from
XBP1/ cross-bred embryonic day 8.5 embryos (12), cultured
in DMEM supplemented with 10% FBS and penicillin/strepto-
mycin. The genotype of the cells was verified by PCR with
primer triplet of P1 (5-atcctgtcttgaaatggcaagtgttgg-3), P2 (5-
tggcaaggctgagcctgatcg-3), and P3 (5-ggaactagagataccactgag-
3), giving rise to a 265-bp band for wild type and a 365-bp band
for XBP1/ homozygous and double bands for XBP1/
heterozygous.
Disturbed Flow—Flow experiments were performed exactly
as described previously (14). Briefly, the disturbed flowwas cre-
ated by placing the flask on a platform shaker (Labnet, model
Rocker 25) with parameters of 2.0-mm culture medium depth,
10-cm length flask, 7° rotating angle and frequency of 0.5 Hz
(i.e. 2 s per cycle), respectively. Unshaken cells were kept for
same duration as static control. For inhibitor assays, the inhib-
itors were included in culture medium for 1 h prior to flow and
maintained during the flow process.
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bro-
mide Cell Proliferation Assay—HUVECs were challenged with
50 mol/liter H2O2 for 24 h after 24 h post-infection with Ad-
null or Ad-XBP1u virus at 10 MOI or with 20 mol/liter H2O2
for 24 h after 72 h post-infection with non-target shRNA or
XBP1 shRNA lentivirus at 10 MOI, followed by 3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cell prolifera-
tion assay with the CellTiter 96 Aqueous One Solution Cell
Proliferation assay kit according to the protocol provided (Pro-
mega). Briefly, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide reagent was diluted at 1:4 with M199 contain-
ing 2% FBS, applied to HUVECs at 300 l/well in 24-well plate
and incubated at 37 °C for 30min to 2h. 300l/well of 0.2%SDS
was then added to stop the reaction. The absorbance atA490 nm
was measured with a laminator luminometer. The relative cell
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survival was defined as the ratio of A490 nm of the test group to
that of control group with that of control group set as 1.0.
Cell Apoptosis Analysis—Mouse embryonic fibroblasts were
challenged with 50 mol/liter H2O2 for 24 h, followed by apo-
ptosis analysis using the Apo-Direct flow cytometry kit
(Chemicon) with protocol provided. PBS was included as con-
trol. Briefly, the treated cells were detached with trypsin and
fixed in solution with 1% paraformaldehyde on ice for 1 h and
washed three times with PBS. The cell pellet was resuspended
in 50l of staining solution (TdT reaction buffer, TdT enzyme,
fluorescein-dUTP) and incubated for 60 min at 37 °C, with
shaking every 15 min. The reaction was stopped through the
addition of 1ml of rinse buffer and washed three times with the
rinse buffer. The cell pellet was resuspended in 500 l of pro-
pidium iodide/RNase A solution and incubated in the dark at
room temperature for 30min, followed by flow cytometry anal-
ysis of fluorescence at 520 nm with a 488-nm Argon laser.
Ex Vivo Experiments—The artery ex vivo survival experi-
ments were performed as described previously (14). Briefly,
arteries were isolated from Tie2-LacZ/ApoE/ mice and cut
into an 2-mm2 segment. The segments were incubated with
0.5ml ofM199mediumplus 15% FBS containing no virus (con-
trol), empty virus (Ad-null), or Ad-XBP1u virus at 1  106
plaque-forming unit/ml in 24-well plate for 6 h. Three seg-
ments were included in each group. The virus solutions were
then removed, and 1 ml of fresh medium was added to each
well. Twenty-four hour post infection, the segments were
treated with PBS or 50 mol/liter H2O2 for 24 h. The segments
were fixedwith 4% formaldehyde and 1% glutaraldehyde in PBS
for 5 min, followed by X-gal staining overnight (24). The seg-
mentsweremounted on slidewith vessel lumen face up. Images
were assessed by Zeiss Axioplan 2 Imaging microscope with
Plan-NEOPLUAR20/0.5objective lenses,AxioCamcameraand
Axiovision software at room temperature and were processed by
AdobePhotoshop software.Cell numberswere countedunder the
microscope. The relative cell number was defined as the ratio of
cell numbers/mm2 of virus-infected group to that of uninfected
control group with that of control set as 1.0.
Plasmid Cloning and Luciferase Activity Assay—A 700-bp
mouseHDAC3 promoter fragment was amplified by PCR using
a primer set of 5-gacactctcgagaatgcctactcgcgttgc-3 and 5-
gtgaccaagcttcgagcctcagctgcc-3, cloned into the XhoI/HindIII
sites of pGL3-Luc (Promega), and verified by DNA sequencing.
The resulting plasmid was designated as HDAC3-Luc. The
XBP1u cDNA sequence was amplified by RT-PCR with a
primer set of 5-ggagctggtaccctggtggtggtggcagcc-3 and 5-tct-
gagaagcttacagtattggatcattcc-3, cloned into the KpnI/HindIII
site of pCMV5-HA vector, and verified by DNA sequencing.
The XBP1u open reading frame is fused to HA tag at the N
terminus, designated as pCMV5-HA-XBP1u. The cloning of
other plasmids, pShuttle2-FLAG-XBP1s, pShuttle2-FLAG-
XBP1u, pShuttle2-FLAG-HDAC3, and the HDAC3 mutant
variants has been described in previous reports (14, 19).
HUVECs were seeded in 12-well plates at 5  104 cells/well
24 h prior to transfection.HDAC3-Luc (0.1g/well) vector was
co-transfected with 0.1 g/well pShuttle2-FLAG-XBP1s or
-XBP1u expression vector into HUVECs with FuGENE 6
(Roche Applied Science). pGL3-Luc basic vector and grp78-luc
vector were included as negative and positive luciferase vector
control, respectively. pShuttle2-lacZ vector was used as an
empty vector control. Renilla-Luc (0.05 g/well) was included
as an internal control. Forty-eight hours later, firefly and
Renilla luciferase activity was assessed with respective assay kit
(Promega). The relative luciferase activity was defined as the
ratio of readout for firefly luciferase to that forRenilla luciferase
with that of control group set as 1.0.
Quantitative PCR—Total cellular RNA was extracted using
Qiagen RNeasy kit according to the protocol provided. Two
microgram RNA was transcribed into cDNA using Improm-II
reverse transcription system (Promega). Twenty nanogram
cDNA (relative to RNA amount) was amplified by PCR with
cyber green solution (Applied Biosystems) in a Sequence Detec-
tion System 7000 (Applied Biosystems). The primers were as fol-
lows:XBP1, 5-agcactcagactacgtgcacct-3 and 5-tgcccaacag gata-
tcagactc-3; HDAC3, 5-catctctgctggtagaagagg-3 and 5-catcata-
gaactcattgggtg-3; HMOX-1, 5-gccagcaacaaagtgcaagatt-3 and
5-tgagtgtaaggacccatcggag-3; Nrf2, 5-cagtggatctgccaactactc-3
and 5-tggagaggatgctgctgaagg-3; and 18s, 5-cccagtaagtgcgggtca-
taa-3 and 5-ccgagggcctcactaaacc-3.
Adenoviral and shRNA Lentiviral Infection—For adenoviral
infection, HUVECs were incubated with Ad-null, Ad-HDAC3,
or Ad-XBP1u virus at 10MOI for 6 h and then cultured in fresh
complete growth medium for time duration indicated in figure
legends. For shRNA lentiviral infection, HUVECs were incubated
with 100 transduction unit/cell of non-target shRNA or XBP1
shRNA or IRE1 shRNA or HDAC3 shRNA lentiviruses in the
presence of 10 mg/ml polybrene for 16 h, followed by culture in
fresh complete growthmedium for 72 h, and subjected to further
treatments.
siRNA Transfection—Human Nrf2 siRNA (sc-37030) was
purchased from Santa Cruz Biotechnology and reconstituted
accordingly. For siRNA transfection assay, HUVECs in 75-ml
flasks were transfected with 50 l of 10 mol/liter control
siRNA or Nrf2 siRNA together with 50 l of Lipofectamine
RNAimax (Invitrogen) according to protocol provided. For virus
infection assays, 48 h post-transfection, the cells were infected
with10MOIAd-null,Ad-XBP1uorAd-HDAC3 viruses and incu-
bated for 24 h, followed byWestern blot analysis. For shear stress
assays, 72hpost-transfection, the cellswere subjected todisturbed
flow for 4 h, followed byWestern blot analysis.
Immunoprecipitation, Immunoblotting, and Immunofluores-
cence Staining—Immunoprecipitation and immunoblotting
were performed according to standard procedures described
elsewhere. One milligram lysate was used for immunoprecipi-
tation, whereas 25gwas used for input or direct immunoblot-
ting. For unconjugated antibody, 2 g of antibody and 10 l of
protein G beads (Sigma) were used for one immunoprecipitation
assay. For agarose-conjugated antibody, 10 l of such beads were
directly used for each immunoprecipitation assay. Immunofluo-
rescence staining was performed using standard procedures.
Briefly, adenovirus-infected or uninfected HUVECs were seeded
on 0.04% gelatin-coated glass slides with or without flow treat-
ment. The cells were fixed withmethanol and permeabilized with
0.1% Triton X-100, blocked with 5% normal swine serum, incu-
bated with primary antibodies, followed by incubation with Alexa
Fluor 488- or 594-labeled secondary antibodies and counterstain-
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ing with DAPI. Images were taken by using SP5 confocal micro-
scope (Leica) and were processed by Adobe Photoshop software.
Magnification was indicated in figures.
Cellular Fractionation—HUVECs were infected with Ad-null,
Ad-XBP1u, or Ad-HDAC3 at 10 MOI for 6 h and incubated for
another 18 h. Fresh medium containing DMSO or 5 mol/liter
AZD2014 were added and incubated for 24 h. The cytosol and
nuclear extracts were harvestedwith procedures described pre-
viously (12).
Chromatin Immunoprecipitation—Chromatin immunopre-
cipitation was performed with ChIP assay kit (17-295, Milli-
pore) according to the protocol provided. Briefly, HUVECs
were subjected to disturbed flow for 2 h, followed by the ChIP
assay. Rabbit anti-XBP1u and anti-XBP1s were used, and nor-
mal rabbit IgG was included as negative control. Six sets of
primer pairs were used to cover the 1.5-kb HDAC3 promoter
region (GenBankTM accession no. AB457579.1). The sequences
include the following: position 1  276, 5-ccacggtcttggc-
catggtgc-3 versus 5-tcggcttcccgaggatctgac-3; position
276  520, 5-tcagatcctcgggaagccgag-3 versus 5-gtttggg-
tccgggtaggggac-3; position520720, 5-cccctacccggacc-
caaactc-3 versus 5-gctgagagcggtggcaggctc-3; position
720960, 5-gagcctgccaccgctctcagc-3 versus 5-ttctccca-
ccctgaccacctg-3; position9601195, 5-gccaggtggtcagg-
gtgggag-3 versus 5-agctctctaccacgaccatgg-3; position
11951467, 5-accatggtcgtggtagagagc-3 versus 5-aagag-
catatatagcccatgttgg-3. Routine PCR was performed using
these primer sets to amplified XBP1u- or XBP1s-bound DNA
fragment.
Statistical Analysis—Data expressed as themean S.E. were
analyzed using GraphPad Prism software (version 5) with t test
for pair-wise comparisons or analysis of variance, when t test
was inappropriate, followed by Dunnett’s multiple comparison
tests, and significance was depicted by asterisks (*, p 0.05).
RESULTS
Disturbed Flow Activates XBP1u in a Similar Manner to
HDAC3—Our previous studies have demonstrated that dis-
turbed flow sustainably activates XBP1 expression and splicing
(14) and that disturbed flow activates HDAC3 in a KDR/PI3K-
Akt pathway-dependent manner (19). In this study, we found
that disturbed flow-induced up-regulation of XBP1u was
ablated by the presence of KDR inhibitor SU5416 and PI3K/Akt
inhibitor LY294002, whereasXBP1 splicing was only ablated by
SU5416 (Fig. 1A). This suggests that XBP1u was regulated by a
similarmechanism toHDAC3 (19). As disturbed flow concom-
itantly up-regulatedHDAC3, XBP1u, andXBP1s, wewondered
whether there was cross-talk between HDAC3 and both XBP1
isoforms. XBP1s is produced by IRE1 activation (11) and
down-regulation of XBP1s can be achieved by knockdown of
IRE1. Knockdown of XBP1 or IRE1 abolished disturbed
flow-induced HDAC3 up-regulation (Fig. 1B), indicating that
there is relationship between both XBP1 isoforms and HDAC3
under disturbed flow. To further examine the involvement of
XBP1s in flow-induced HDAC3 up-regulation, exogenous
overexpression of XBP1s was introduced into HUVECs via
adenoviral gene transfer. As shown in Fig. 1C, overexpression of
XBP1s actually decreased HDAC3 protein due to transcrip-
tional repression as revealed by theHDAC3-Luc reporter anal-
ysis (Fig. 1D). Overexpression of XBP1u had no effect on
HDAC3 transcription (Fig. 1D) but antagonized the effect of
XBP1s and protected HDAC3 protein levels (Fig. 1E). A ChIP
assay revealed that both XBP1u and XBP1s could bind to the
960  1195 region of HDAC3 promoter (Fig. 1F). Under
static condition, more XBP1u bound to this region, whereas
during disturbed flow,more XBP1s bound to this region. These
results suggest that there may be a cross-talk between HDAC3
and XBP1u.
FIGURE 1. XBP1u protein was essential for disturbed flow-induced
HDAC3up-regulation. A, VEGF-PI3K/Akt pathwaywas involved in disturbed
flow (4 h)-induced up-regulation of XBP1 expression and splicing.DM, DMSO
(vehicle control); SU, SU5416 (1 mol/liter, VEGF receptor inhibitor); PD,
PD98059 (5 mol/liter, ERK inhibitor); LY, LY294002 (5 mol/liter, PI3K/Akt
inhibitor). B, knockdown of XBP1 or IRE1 abolished disturbed flow (4 h)-in-
duced HDAC3 up-regulation. UT, untransfected; NT, non-target shRNA trans-
fected; Xsh, XBP1 shRNA transfected; Ish, IRE1 shRNA transfected. Disturbed
flow was applied to HUVECs 72 h post transfection for 4 h. C, Overexpression
of spliced XBP1 down-regulated HDAC3 protein. FLAG indicates the exoge-
nous XBP1s protein. D, spliced XBP1 suppressed HDAC3 gene transcription.
RLA, relative luciferase activity. pGL3-luc basic vector was included as nega-
tive control, whereas grp78-Luc vector was used as positive control. Mock,
pShuttle-LacZ plasmid; XBP1s, pShuttle-FLAG-XBP1s plasmid; XBP1u,
pShuttle-FLAG-XBP1u plasmid. E, XBP1u antagonized XBP1s on the regula-
tion of HDAC3 protein. HUVECs were co-infected with Ad-XBP1s and
Ad-XBP1u at 10 MOI each for 48 h. Ad-null was included as control and to
compensate the MOI. FLAG indicates the exogenous XBP1s and XBP1u pro-
teins. F, XBP1u and XBP1s differentially bound to HDAC3 promoter in
response to disturbed flow. ChIP assaywas performed to analyze the binding
of XBP1u and XBP1s to the HDAC3 promoter in static and disturbed flow-
treatedHUVECs (4 h). Six sets of primer pairs covered the11467 region
(upper panel), and PCR showed that XBP1u and XBP1s differentially bound to
9601195 region in response to disturbed flow (lower panel). SS, shear
stress. Data presented are representative or average of three independent
experiments.
*, p 0.05.
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XBP1u Level Is Related to EC Survival under Oxidative
Stress—HDAC3 has been demonstrated to protect cells from
oxidative stress (19, 25). To assess whether up-regulation of
XBP1u has a similar protective effect, arterial segments were
isolated from Tie2-LacZ/ApoE/mice and infected with Ad-
null or Ad-XBP1u viruses followed by 50mol/liter H2O2 chal-
lenge. In thesemice, the-galactosidase is selectively expressed
in endothelial cells and some progenitor cells driven by theTie2
promoter. X-gal staining reveals the endothelium. Overexpres-
sion of XBP1u significantly reduced H2O2-induced EC loss
from the vessel wall (Fig. 2A), which was further confirmed by
in vitro experiments challenging HUVECs with 50 mol/liter
H2O2 (Fig. 2B). In contrast, knockdown of XBP1 via shRNA
lentiviral infection slightly increased the basal level of cell apo-
ptosis but significantly augmented H2O2-induced HUVECs
apoptosis even at a low concentration (20 mol/liter) (Fig. 2C).
Wild type and XBP1 null (XBP1/) embryonic fibroblasts
were isolated from XBP1/ cross-bred mouse embryonic day
8.5 embryos and verified by PCR (Fig. 2D). Spontaneously apo-
ptotic cells were higher inXBP1 null cells than that in wild type
cells (4% versus 1%), which dramatically increased after 20
mol/liter H2O2 challenge (35% versus 2.5%, Fig. 2E). These
results suggest that XBP1u is essential for EC survival especially
under oxidative stress.
XBP1u and HDAC3 Activates HO-1 in an Nrf2-dependent
Manner—The degradation of heme produces biliverdin, ion,
and carbonmonoxide, in which HO-1 plays a rate-limiting role
(4). It has been reported that HO-1 protects human ECs and
vascular SMCs survival under H2O2 challenge (26, 27). There-
fore, we wondered whether the increase of XBP1u-induced cell
survival under H2O2 challenge was due to HO-1. To test this,
the HO-1 inhibitor, Tin protoporphyrin IX (28), was included
in H2O2 challenge experiments. Indeed, the presence of Tin
protoporphyrin IX abolished XBP1u-mediated cell survival
(Fig. 3A), suggesting that XBP1u promotes EC survival under
oxidative stress via HO-1. Further experiments revealed that
the overexpression of either XBP1u or HDAC3 up-regulated
HMOX-1 gene expression at the mRNA (Fig. 3B) and protein
(Fig. 3C) levels. The mRNA level of the HMOX-1 upstream
FIGURE 2.XBP1u protected cell survival under oxidative stress. A, overex-
pression of XBP1u increased EC survival ex vivo under 50mol/liter H2O2. The
left panel shows the X-gal staining images, whereas the right panel indicates
the relative cell numbers that were defined as cells/mm2 with that of unin-
fected (CTL)/PBS group set as 1.0. B, overexpression of XBP1u attenuated
H2O2-induced cell loss in HUVECs. C, knockdown of XBP1 enhanced H2O2 (20
mol/liter)-induced cell loss in HUVECs. D, H2O2 induced significant cell apo-
ptosis inXBP1/mouse embryonic fibroblasts. The left panel shows themor-
phology of mouse embryonic fibroblasts isolated from wild type (XBP1/)
and XBP1-null (XBP1/) embryos and the PCR strategy to verify the disrup-
tion of the XBP1 gene. The right panel indicates the effect of 20 mol/liter
H2O2 on cell apoptosis. Data presented are representatives or average of
three independent experiments. *, p 0.05.
FIGURE 3. XBP1u-mediated cell survival was through regulation of HO-1
expression. A, HO-1 inhibitor SnPPIX abolished the protective effect of
XBP1u overexpression on cell survival under H2O2 challenging. B, quantita-
tive RT-PCR revealed that over-expression of XBP1u or HDAC3 up-regulated
HMOX-1mRNA level without effect on Nrf2mRNA level. C, Western blot anal-
ysis showed that overexpression of XBP1u or HDAC3 up-regulated both Nrf2
and HO-1 protein levels. D, knockdown of Nrf2 abolished XBP1u or HDAC3-
induced HO-1 expression. CTLsi, control siRNA. E, overexpression of XBP1u or
HDAC3 increased Nrf2 nuclear translocation and HO-1 expression in the
infected and adjacent cells. Double immunofluorescence staining was per-
formedwith anti-Akt1 (red) and anti-Nrf2 (green) antibodies orwith anti-FLAG
(red) for exogenous XBP1u or HDAC3 and anti-HO-1 (green) antibodies. Data
presented are representatives or average from three independent experi-
ments. *, p 0.05.
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transcription factor Nrf2 (29) remained unchanged (Fig. 3B),
but the protein levelwas significantly up-regulated byXBP1uor
HDAC3 (Fig. 3C), which might be through post-translational
stabilization (30). Knockdown of Nrf2 by siRNA abolished
Ad-XBP1u-induced and significantly attenuated Ad-HDAC3-
induced HO-1 proteins (Fig. 3D). Immunofluorescence stain-
ing revealed that overexpression of XBP1u or HDAC3
increased the nuclear localization of Nrf2 protein (Fig. 3E).
Importantly, overexpression of XBP1u or HDAC3 not only
increasedHO-1 protein in the infected cells but also in adjacent
cells (Fig. 3E), suggesting that some secreted factors are
involved. These results suggest that XBP1u or HDAC3 pro-
motes EC survival under oxidative stress through Nrf2-medi-
ated HO-1 expression.
XBP1u and HDAC3 Activate Akt1 Phosphorylation via mTOR
Complex—The PI3K/Akt pathway plays a key role in HO-1
expression (31). Our previous study has demonstrated that
overexpression of HDAC3 increases Akt phosphorylation (19).
In this study, Western blot analysis revealed that overexpres-
sion of XBP1u induced simultaneous increase inAkt phosphor-
ylation and HO-1 protein in a dose- and time-dependent man-
ner (Fig. 4, A and B). Knockdown of XBP1 decreased the basal
FIGURE 4.XBP1was essential for disturbed flow-induced up-regulation of HO-1. A, overexpression of XBP1u up-regulated HO-1 and Akt phosphorylation
in a dose-dependent manner. HUVECs were infected with Ad-XBP1u at MOI indicated for 24 h, followed by Western blot analysis. Ad-null was included to
compensate theMOI. B, overexpression of XBP1umaintained a high level of Akt1 phosphorylation andHO-1 expression. HUVECswere infectedwith Ad-XBP1u
at 10MOI for 24 h and 48 h, followedbyWestern blot analysis. Ad-null was included as control. FLAG indicates the exogenous XBP1u.C, knockdownof XBP1 via
shRNA lentivirus (XBP1sh) decreased basal level of Akt1 phosphorylation and HO-1 expression. Non-target shRNA lentivirus (NTsh) was included as control. D,
knockdown of XBP1 via shRNA lentivirus (XBP1sh) abolished disturbed flow-induced HO-1 expression. Non-target shRNA lentivirus (NTsh) was included as
control. E, Nrf2was necessary for flow-inducedHO-1 expression. HUVECswere transfectedwith control siRNA (CTLsi) or Nrf2 siRNA (Nrf2si) for 72 h, followedby
disturbed flow for 4 h. F, flow stabilized Nrf2 via post-translational modification. HUVECs were treated with 1 mol/liter actinomycin D (AD) or 30 mg/liter
cycloheximide (CH) for 1 h, followed by disturbed flow for 4 h or kept at static conditions in the presence of the inhibitors. DMSO (DM) was included as vehicle
control. G, AZD2014 abolished Ad-XBP1u (X1u) or Ad-HDAC3 (HD3)-induced pAkt Ser-473 phosphorylation, Nrf2 nuclear translocation, and HO-1 expression.
HUVECs were infected with Ad-null or Ad-XBP1u or Ad-HDAC3 at 10 MOI for 24 h and then treated with 5 mol/liter AZD2014 for 24 h, followed by cellular
fraction isolation and Western blot analysis. DMSO was included as vehicle control. The anti-FLAG antibody was included to detect exogenous XBP1u and
HDAC3. Antibodies against-tubulin andhistoneH3were included to indicate cytosol andnuclear extract, respectively. The samples fromcytosol andnuclear
extraction were run on separate gels but performed Western blot at the same time and exposed to x-ray film exactly at the same time period. H, AZD2014
attenuatedXBP1u/HDAC3-inducedAkt1phosphorylation in nucleus. HUVECswere infectedwithAd-null or Ad-XBP1uor Ad-HDAC3 at 10MOI for 24h and then
treated with 5mol/liter AZD2014 for 24 h, followed by double immunofluorescence staining with anti-mTOR (red) and anti-pAkt Ser-473 (green) antibodies.
I, AZD2014 reduced flow-induced Nrf2 nuclear translocation. HUVECs were treated with 5 mol/liter AZD2014 for 1 h, followed by disturbed flow for 4 h or
being kept at static conditions in the presence of ZAD2014. DMSOwas included as vehicle control. Double immunofluorescence stainingwas performedwith
anti-mTOR (red) and anti-Nrf2 (green) or pAkt Ser-473 (green) antibodies. Data presented are representatives of three independent experiments.
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level of Akt phosphorylation and HO-1 protein (Fig. 4C). Dis-
turbed flow is reported to activate HO-1 expression (32). We
also detected the up-regulation of HO-1, Nrf2, and Akt1 phos-
phorylation by disturbed flow (Fig. 4D). As expected, these
effects were totally abolished by XBP1 knockdown via shRNA
lentiviral infection (Fig. 4D). Further experiments confirmed
that Nrf2 was necessary for flow-induced HO-1 up-regulation,
as siRNA-mediated knockdown of Nrf2 abolished flow-in-
ducedHO-1 expression (Fig. 4E). The addition of the transcrip-
tion inhibitor (actinomycin D) or translation inhibitor (cyclo-
heximide) also abolished flow-induced HO-1 up-regulation
(Fig. 4F). The addition of actinomycin D and especially cyclo-
heximide reduced the basal level of Nrf2. However, disturbed
flow still up-regulated Nrf2 at the protein level (Fig. 4F). These
results suggest that the increase in observedNrf2 protein is due
to post-translational modification, whereas the increase in
observed HO-1 protein is due to de novo biosynthesis. The
phosphorylation of the Ser-473 site in Akt1 protein is reported
to be activated by the Rapamycin-insensitive companion of
mammalian target of rapamycin-mTOR complex (mTORC2)
(33, 34). To testwhetherXBP1u orHDAC3 inducedAkt1 phos-
phorylation in a similar manner, the Rapamycin-insensitive
companion of mammalian target of rapamycin-mTOR com-
plex inhibitor, AZD2014 (35) was added to Ad-XBP1u or
Ad-HDAC3-infected cells. Cellular fractionation was per-
formed to analyze Akt1 phosphorylation and Nrf2 nuclear
translocation. Overexpression of XBP1u or HDAC3 increased
Akt1 Ser-473 phosphorylation, the nuclear translocation of
phosphorylated Akt1 and Nrf2 and up-regulated HO-1 (Fig.
4G). However, in the presence of 5 mol/liter of AZD2014, all
of these effects were diminished (Fig. 4G). The presence of
XBP1u or HDAC3-induced pAkt1 Ser-473 in the nucleus was
confirmed by immunofluorescence staining. This was signifi-
cantly attenuated by AZD2014 (Fig. 4H). The presence of
AZD2014 also abolished flow-induced Nrf2 nuclear transloca-
tion (Fig. 4I). These results suggest that XBP1 is essential for
basal and disturbed flow-induced HO-1 expression via regula-
tion of theAkt1/Nrf2 pathway in aRapamycin-insensitive com-
panion of mammalian target of rapamycin-mTOR dependent
manner.
XBP1u Physically Interacts with HDAC3—As described
above, both XBP1u and HDAC3 up-regulate HO-1 expression,
whereas flow-induced HDAC3 is XBP1-dependent. Therefore,
we hypothesized that there was cross-talk between XBP1u and
HDAC3 during the regulation of HO-1. To test this, co-expres-
sion of HDAC3 and XBP1u was first introduced into HUVECs
by co-infection with two viruses. As shown in Fig. 5A, overex-
pression of either XBP1u or HDAC3 alone up-regulated Akt1
phosphorylation, Nrf2 and HO-1, whereas co-expression of
XBP1u and HDAC3 had a synergistic effect. Further experi-
ments revealed that knockdown ofHDAC3 attenuated XBP1u-
induced Akt1 phosphorylation and HO-1 expression (Fig. 5B).
Co-immunoprecipitation assays revealed that XBP1u physi-
cally bound to HDAC3 in transfected cells (Fig. 5C). Using
truncated HDAC3 mutants, the binding domain in HDAC3
molecule could be defined to the amino acid 201323 region
(Fig. 5D). Immunoprecipitation with antibody against endoge-
nous XBP1u revealed that XBP1u bound to HDAC3 and Akt1
under disturbed flow (Fig. 5E). Double immunofluorescence
staining showed that mTOR/Akt1, Akt1/HDAC3, Akt1/
XBP1u, andHDAC3/XBP1u co-localized in the cytoplasm (Fig.
5F). These results suggest XBP1u/HDAC3/Akt1/mTOR may
form a complex to regulate Akt1 phosphorylation, leading to
Nrf2 stabilization and HO-1 expression.
DISCUSSION
The maintenance of redox homeostasis is essential for cell
survival and normal cellular functions. It is well known that
disturbed flow can activate oxidative stress, which is proathero-
genic. In this study, we demonstrate that disturbed flow can
also activate anti-oxidative effects via the up-regulation of
HO-1 protein in an XBP1u/HDAC3/Akt1/Nrf2 pathway-de-
pendent manner. XBP1u, HDAC3, Akt1, and mTORmay form
a complex, which provides a novel mechanism in regulating
HO-1 expression, leading to cell survival under oxidative stress.
HMOX-1 belongs to a group of antioxidant response element
(ARE)-regulated genes. The ARE in the promoter of HMOX-1
is also a shear stress response element, through which the tran-
scription is up-regulated by hemodynamic forces, including
laminar shear stress (32, 36–38), oscillatory shear stress (32,
37), and cyclic stretch (39) in ECs and/or smooth muscle cells.
Laminar shear stress is more effective as compared with oscil-
latory shear stress, but the latter seemsmore effective over long
time periods (32, 37). The ARE-regulatedHMOX-1 expression
is mediated by the antioxidant transcription factor Nrf2 (40).
Shear stress activates Nrf2 posttranslational stabilization and
nuclear localization (9, 41). Several signal pathways have been
reported to stabilize Nrf2 (42), one of which is PI3K/Akt (31). It
is well known that shear stress activates Akt phosphorylation.
Thus, flow-induced Akt phosphorylation may be responsible
forNrf2 stabilization, leading toHO-1 up-regulation.However,
the signal between the shear stress sensor and Akt/Nrf2
remains unclear. In this study, we observed that oscillatory flow
up-regulated XBP1u, HDAC3, Akt phosphorylation, and Nrf2
and HO-1 protein levels, of which the latter four depended on
the presence of XBP1. Knockdown of XBP1 via shRNA lentivi-
ral infection not only abolished flow-induced but also
decreased the basal level of Akt1 phosphorylation and HO-1
expression. In contrast, overexpression of XBP1u inducedAkt1
phosphorylation and HO-1 up-regulation at mRNA and pro-
tein levels. XBP1u does not affect the mRNA level of Nrf2, but
increased its protein level potentially through posttranslational
stabilization. Indeed, in the presence of transcription and trans-
lation inhibitors, disturbed flow still increased Nrf2 protein.
Knockdown of Nrf2 abolished flow-induced HO-1 expression.
These results suggest that XBP1may play a fundamental role in
HO-1 expression in anNrf2-dependentway. There aremultiple
mechanosensors on the cell surface, which transform the
mechanical forces into cellular signaling. One of these sensors
is theVEGF receptor,which canbe activated by flow in a ligand-
independent manner (43). In the present study, we found that
VEGF receptor inhibitor SU5416 abolished flow-induced
XBP1u up-regulation. Therefore, it is possible that XBP1u
functions as a signal transducer between the mechanosensor,
VEGF receptor, and the Akt1/Nrf2/HO-1 pathway.
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Oxidized lipids are a known atherosclerosis risk factor, trig-
gering oxidative stress and ER stress. The three ER stress signal
pathways IRE1/XBP1 splicing, ATF6, and PERK phosphory-
lation are activated with concomitant up-regulation of HO-1
(44, 45), whereas the up-regulation of HO-1 may inhibit ER
stress-triggered EC apoptosis (46). Concerning the ER stress
response, most studies have focused on the XBP1 splicing
event, the role of XBP1u has been underestimated. In the pres-
ent study, we found that XBP1u is involved in the basal level
expression of HO-1 in cultured ECs and responsible for flow-
inducedHO-1 up-regulation and that overexpression ofXBP1u
could induce HO-1 expression. Under ER stress, the activation
of ATF6 can trigger XBP1 transcription, leading to the increase
of both XBP1u and XBP1s (10, 11, 47). Therefore, a protective
role of XBP1u via HO-1 in ER stress may be studied.
Our previous study demonstrated that HDAC3 protects ECs
from oxidative stress via Akt phosphorylation (19). In this
study, we found that overexpression of HDAC3 could stabi-
lize Nrf2 and up-regulateHMOX-1 transcription. HO-1 may
be the final effector for antioxidant protection. Flow-in-
duced HDAC3 and Akt1 phosphorylation is XBP1-depen-
dent, whereas XBP1u-induced Akt1 phosphorylation and
FIGURE 5.XBP1physically interactedwithHDAC3.A, XBP1u andHDAC3 synergistically activatedHO-1 expression. HUVECswere co-infectedwith Ad-XBP1u
andAd-HDAC3 at 10MOI each for 24h, followedbyWesternblot analysis. Ad-null viruswas includedas control and to compensate theMOI. FLAGantibodywas
used to detect exogenous XBP1u and HDAC3. B, knockdown of HDAC3 via shRNA lentivirus (HDAC3sh) attenuated Ad-XBP1u-induced HO-1 expression.
Non-target shRNA lentivirus (NTsh) was included as control. C, XBP1u physically interacted with HDAC3. HEK293 cells were co-transfected with HA-XBP1u and
FLAG-HDAC3 plasmids, followed by immunoprecipitation with anti-HA antibody and Western blot analysis with anti-FLAG and anti-HA antibodies. D, XBP1u
bound to amino acid 201–323 region inHDAC3molecule. The left panel indicates the schematic illustrationofHDAC3 truncatedmutants. The right panel shows
the interaction of XBP1u and truncated HDAC3 as revealed by immunoprecipitation assays. E, disturbed flow increased XBP1u association with HDAC3/Akt1.
Co-immunoprecipitation with anti-XBP1u antibodywas performed on static and disturbed flow (4 h)-treated cells, followed byWestern blot with anti-HDAC3
or Akt1 and anti-XBP1u antibodies. F, disturbed flow induced mTOR/Akt1/HDAC3/XBP1u complex formation in the cytoplasm. Double immunofluorescence
stainingwas performedon static anddisturbed flow (4 h)-treated cells. Antibodies are indicatedwith redor green letters reflecting the color in the images. Data
presented are representatives of three independent experiments.
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HO-1 expression could be attenuated by HDAC3 knockdown.
Moreover, XBP1u and HDAC3 had synergistic effect on Akt1
phosphorylation and HO-1 expression. However, the flow-up-
regulated XBP1u and HDAC3 can be attenuated by the pres-
ence of PI3K/Akt inhibitor Ly294002. All of these data imply
that XBP1u, HDAC3, and Akt1 may form a complex to regulate
Nrf2 stabilization andHO-1 expression. Indeed, Akt1 binds to the
amino acid 131–201 region in HDAC3 molecule (19), whereas
XBP1u binds to the amino acid 201–323 region. Immunoprecipi-
tation with anti-XBP1u antibody could pull down both HDAC3
and Akt1, whereas double immunofluorescence staining revealed
that these three molecules co-localized in the cytoplasm. Impor-
tantly, the complexmay includemTOR. It has been reported that
the phosphorylation of Akt serine 473 site is activated by
mTORC2 (33, 34). In our study, the mTORC2 inhibitor,
AZD2014, abolished XBP1u- or HDAC3-induced Akt Ser-473
phosphorylation,Nrf2 nuclear translocation, andHO-1 expres-
sion, suggesting that XBP1u or HDAC3-induced Akt Ser-473
phosphorylation is mediated by mTORC2. Furthermore, dis-
turbed flow induces mTOR and Akt1 co-localization in the
cytoplasm. HDAC3 may function as a bridge to bring together
XBP1u, Akt1, and mTORC2 to form a complex, leading to
XBP1u/HDAC3 stabilization and Akt1 phosphorylation. Our
studies indicate that HDAC3 plays a positive role in the regula-
tion of HO-1 expression and in protecting ECs under oxidative
stress. A recent report from Su et al. (48) showed that sul-
foraphane-induced HO-1 expression with a decrease in HDAC
activity and the protein levels of HDAC1–4 in skin cells, sug-
gesting a negative role of HDAC3 in HO-1 expression. The
discrepancy may be due to the different cell models and the
stimuli used.
In summary, disturbed flow may activate the VEGF receptor
in a ligand-independentmanner, which in turn induces the for-
mation of a complex among mTORC2, Akt1, XBP1u, and
HDAC3. The formation of this complex stabilizes both XBP1u
and HDAC3 and activates Akt1 phosphorylation, leading to Nrf2
stabilization. Nrf2 translocates into the nucleus and binds to the
ARE in the HMOX-1 gene promoter, promoting HMOX-1 tran-
scription. HO-1 catalyzes heme degradation and produces the
antioxidant biliverdin and carbon monoxide. Through these
mechanisms, ECs protect themselves from disturbed flow-in-
ducedoxidative stress, thereforemaintaining the redoxhomeosta-
sis (Fig. 6).
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